This inventor holds 1 USPTO granted patent and 7 published patent applications and 1 EPO patent. Top assignee: Korea Institute of Radiological & Medical Sciences. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations in Cancer Treatment by Jae-Min Jeong
Introduction
Jae-Min Jeong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the development of innovative treatments for malignant tumors. His work focuses on utilizing genetic components to enhance cancer therapies.
Latest Patents
Jae-Min Jeong holds a patent for a pharmaceutical composition aimed at treating malignant tumors. This composition includes a human p31 gene encoding protein, which has been shown to suppress cancer cell growth, induce apoptosis, and effectively kill cells by overexpressing p31 in solid malignant tumor cells. This innovative approach offers promising potential for gene therapy in oncology.
Career Highlights
Jae-Min Jeong is affiliated with the Korea Institute of Radiological and Medical Sciences, where he conducts research and develops new therapeutic strategies. His work has garnered attention for its potential to revolutionize cancer treatment methodologies.
Collaborations
He collaborates with esteemed colleagues, including Kee-Ho Lee and Sang-Hoon Kim, to advance research in the field of cancer therapy. Their combined expertise contributes to the development of effective treatment options for patients.
Conclusion
Jae-Min Jeong's innovative work in cancer treatment exemplifies the potential of genetic therapies in modern medicine. His contributions are paving the way for more effective and targeted approaches to combat malignant tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile